Page last updated: 2024-08-21

alpha-aminopyridine and Bone Diseases

alpha-aminopyridine has been researched along with Bone Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, Z; Chen, J; Chen, Q; Gu, H; Guo, X; He, D; He, H; He, J; Huang, X; Wang, G; Yan, H; Yang, Y; Yi, Q; Zhang, E; Zhao, Y1
Fitter, S; Gan, ZY; Martin, SK; To, LB; Zannettino, AC1

Other Studies

2 other study(ies) available for alpha-aminopyridine and Bone Diseases

ArticleYear
Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease.
    Haematologica, 2018, Volume: 103, Issue:8

    Topics: Aminopyridines; Animals; Apoptosis; Benzamides; Bone Diseases; Bone Resorption; Cell Cycle Checkpoints; Cell Line, Tumor; Cells, Cultured; Histone Deacetylase Inhibitors; Humans; Mice; Multiple Myeloma; Osteoblasts; Osteoclasts

2018
The effect of the PI3K inhibitor BKM120 on tumour growth and osteolytic bone disease in multiple myeloma.
    Leukemia research, 2015, Volume: 39, Issue:3

    Topics: Aminopyridines; Animals; Apoptosis; Blotting, Western; Bone Diseases; Cell Cycle; Cell Proliferation; Disease Models, Animal; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; Mice; Mice, Inbred C57BL; Morpholines; Multiple Myeloma; Osteoclasts; Osteolysis; Phosphoinositide-3 Kinase Inhibitors; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2015